A Study of a Combination of Four Drugs in Patients With Recent HIV Infection

NCT00002233 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Indinavir sulfate
DRUG: Abacavir sulfate
DRUG: Amprenavir
DRUG: Lamivudine

Sponsor

Glaxo Wellcome